This study introduces a novel approach using electroacupuncture (EA) to mitigate HFD‐accelerated AD pathology, focusing on the regulatory role of transcription factors TFEB and TFE3 in ALP and their potential modulation by EA. The gene discussed is TFE3; the disease is Alzheimer disease.